THERAPY Risk of metformin use in patients with T2DM and advanced CKD

被引：9
|
作者：
Schernthaner, Guntram [1 ]
Schernthaner-Reiter, Marie Helene [2 ]
机构：
[1] Rudolfstiftung Hosp, Dept Med 1, A-1030 Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 3, Clin Div Endocrinol & Metab, A-1090 Vienna, Austria
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2015年 / 11卷 / 12期
关键词：
KIDNEY-DISEASE; MORTALITY;
D O I：
10.1038/nrendo.2015.132
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In a new study published in The Lancet Diabetes & Endocrinology, metformin use is associated with significantly increased all-cause mortality in patients with type 2 diabetes mellitus and stage 5 chronic kidney disease (CKD). The findings support current recommendations that metformin should not be used in patients with stage 5 CKD.
引用
收藏
页码：697 / 698
页数：2
相关论文
共 50 条
  • [21] Impact of Treatment with Sitagliptin or Sulfonylurea on Modifiable CV Risk Factors in T2DM with CKD
    Ommen, Elizabeth S.
    Xu, Lei
    Engel, Samuel S.
    [J]. DIABETES, 2015, 64 : A656 - A656
  • [22] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    [J]. ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
  • [23] Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD
    Al-Obaide, Mohammed A. I.
    Singh, Ruchi
    Datta, Palika
    Rewers-Felkins, Kathy A.
    Salguero, Maria V.
    Al-Obaidi, Ibtisam
    Kottapalli, Kameswara Rao
    Vasylyeva, Tetyana L.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2017, 6 (09)
  • [24] Designing a new therapy for T2DM
    Greenhill, Claire
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (12) : 684 - 684
  • [25] Antihelminthic drug for T2DM therapy?
    Joana Osório
    [J]. Nature Reviews Endocrinology, 2014, 10 (12) : 702 - 702
  • [26] Effects of pioglitazone addition to metformin or sulfonylurea therapy on serum lipids in patients with T2DM - 2-year data
    Mariz, S
    Urquhart, R
    Moules, I
    Tan, MH
    Edwards, G
    [J]. DIABETES, 2004, 53 : A137 - A137
  • [27] Designing a new therapy for T2DM
    Claire Greenhill
    [J]. Nature Reviews Endocrinology, 2019, 15 : 684 - 684
  • [28] Defining genetic risk of T2DM
    Claire Greenhill
    [J]. Nature Reviews Endocrinology, 2019, 15 : 438 - 438
  • [29] Defining genetic risk of T2DM
    Greenhill, Claire
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (08) : 438 - 438
  • [30] T2DM MODIFIES THE RELATIONSHIP BETWEEN CAC AND ADVERSE KIDNEY OUTCOME IN PATIENTS WITH CKD
    Yun, Hae-Ryong
    Han, Seung Hyeok
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I573 - I574
12345